1. Home
  2. INBS vs ALZN Comparison

INBS vs ALZN Comparison

Compare INBS & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.91

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

N/A

Current Price

$1.06

Market Cap

7.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
ALZN
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.1M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
INBS
ALZN
Price
$2.91
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
41.6K
177.9K
Earning Date
05-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
68.65
22.99
EPS
N/A
N/A
Revenue
$1,980,484.00
N/A
Revenue This Year
$778.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.51
52 Week High
$24.90
$8.22

Technical Indicators

Market Signals
Indicator
INBS
ALZN
Relative Strength Index (RSI) 25.10 26.16
Support Level $1.49 N/A
Resistance Level $7.25 $2.59
Average True Range (ATR) 0.30 0.19
MACD 0.05 -0.11
Stochastic Oscillator 0.74 5.09

Price Performance

Historical Comparison
INBS
ALZN

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: